Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 5/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14289372 | 0.90 | ALDH1A1 (0.35) | OPRM1OPRD1OPRK1ACHE | |
| SCHEMBL12428211 | 0.84 | ADRB2 (0.38) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428224 | 0.84 | ADRB2 (0.36) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428210 | 0.83 | ADRB2 (0.37) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428221 | 0.82 | ADRB2 (0.35) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428223 | 0.82 | ADRB2 (0.37) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428209 | 0.81 | ADRB2 (0.36) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428226 | 0.81 | ADRB2 (0.36) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428196 | 0.80 | ADRB2 (0.40) | ADRB2ADRB1ADRB3OPRM1OPRD1 | |
| SCHEMBL12428133 | 0.80 | ALDH1A1 (0.42) | ADRB2ADRB1ADRB3OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977570-B2 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090084441-A1 | Dye-sensitized photoelectric conversion device | CRY1, H1-5, H1-0 | ADRB2 1608/4885ADRB1 1522/4885ADRB3 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.